TCN2
Basic information
Region (hg38): 22:30607003-30627271
Links
Phenotypes
GenCC
Source:
- transcobalamin II deficiency (Definitive), mode of inheritance: AR
- transcobalamin II deficiency (Strong), mode of inheritance: AR
- transcobalamin II deficiency (Supportive), mode of inheritance: AR
- transcobalamin II deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Transcobalamin II deficiency | AR | Allergy/Immunology/Infectious; Biochemical | The condition can include neurocognitive impairment, hematologic anomalies (eg, anemia, panyctopenia), susceptibility to recurrent and severe infections, and gastrointestinal sequelae, and cobalamin treatment can result in prevention and/or clinical improvement, including related to developmental parameters; Awareness of immunodeficiency may allow prompt treatment of infections | Allergy/Immunology/Infectious; Biochemical; Gastrointestinal; Hematologic; Neurologic | 5096637; 4138209; 128427; 3143215; 309761; 1743216; 7849710; 19373259 |
ClinVar
This is a list of variants' phenotypes submitted to
- Transcobalamin_II_deficiency (616 variants)
- Inborn_genetic_diseases (78 variants)
- not_provided (47 variants)
- TCN2-related_disorder (17 variants)
- not_specified (5 variants)
- Pancytopenia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TCN2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000000355.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 189 | 197 | ||||
| missense | 213 | 19 | 237 | |||
| nonsense | 12 | 18 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 25 | 34 | ||||
| splice donor/acceptor (+/-2bp) | 12 | |||||
| Total | 43 | 21 | 220 | 208 | 7 |
Highest pathogenic variant AF is 0.00029429587
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TCN2 | protein_coding | protein_coding | ENST00000215838 | 9 | 20441 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00000105 | 0.940 | 125675 | 0 | 73 | 125748 | 0.000290 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -2.12 | 322 | 231 | 1.39 | 0.0000128 | 2760 |
| Missense in Polyphen | 95 | 73.17 | 1.2983 | 965 | ||
| Synonymous | -4.19 | 149 | 96.6 | 1.54 | 0.00000543 | 873 |
| Loss of Function | 1.81 | 13 | 22.2 | 0.585 | 0.00000133 | 232 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000756 | 0.000756 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000163 | 0.000163 |
| Finnish | 0.0000924 | 0.0000924 |
| European (Non-Finnish) | 0.000369 | 0.000360 |
| Middle Eastern | 0.000163 | 0.000163 |
| South Asian | 0.000261 | 0.000261 |
| Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Primary vitamin B12-binding and transport protein. Delivers cobalamin to cells. {ECO:0000269|PubMed:8443384}.;
- Disease
- DISEASE: Transcobalamin II deficiency (TCN2 deficiency) [MIM:275350]: Results in various forms of anemia. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Vitamin digestion and absorption - Homo sapiens (human);Vitamin B12 Metabolism;One Carbon Metabolism;Cobalamin (Cbl, vitamin B12) transport and metabolism;Metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
(Consensus)
Recessive Scores
- pRec
- 0.565
Intolerance Scores
- loftool
- 0.808
- rvis_EVS
- 1.93
- rvis_percentile_EVS
- 97.49
Haploinsufficiency Scores
- pHI
- 0.211
- hipred
- Y
- hipred_score
- 0.542
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.411
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tcn2
- Phenotype
Gene ontology
- Biological process
- cobalt ion transport;cobalamin metabolic process;cobalamin transport
- Cellular component
- extracellular region;extracellular space;endosome;lysosomal lumen
- Molecular function
- protein binding;cobalamin binding;metal ion binding